Article info
PDFReview
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
- Correspondence to Dr Ioannis A Voutsadakis, Sault Area Hospital, Sault Sainte Marie, ON P6B 0A8, Canada; ivoutsadakis{at}yahoo.com
Citation
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
Publication history
- Received August 12, 2019
- Revision received September 16, 2019
- Accepted September 24, 2019
- First published November 27, 2019.
Online issue publication
January 08, 2022
Article Versions
- Previous version (6 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.